Human tumors studied with genetic markers - PubMed (original) (raw)
- PMID: 825156
Human tumors studied with genetic markers
P J Fialkow. Birth Defects Orig Artic Ser. 1976.
Abstract
Genetic marker systems have been employed to investigate the origin and development of many human tumors. The type of information already gained with such systems includes the probable single cell origin of chronic myelocytic leukemia in a marrow stem cell. The G-6-PD system has also confirmed the hypothesis that at least some hereditary and viral tumors have multiple cell origin. However, Burkitt lymphoma, the malignancy in man for which there is a great amount of circumstantial evidence for a viral cancer, has a clonal origin. Of particular interest is the demonstration that early relapses after remissions of Burkitt lymphoma represent reemergence of the original malignant cell lines, whereas some late recurrences may be the result of newly induced malignant clones. Similarly, some recurrences of acute lymphoblastic leukemia in patients treated with marrow transplantation may be new occurrences of disease. These observations have important implications for the etiology and pathogenesis of Burkitt lymphoma and acute lymphoblastic leukemia.
Similar articles
- Immunoglobulin and glucose-6-phosphate dehydrogenase as markers of cellular origin in Burkitt lymphoma.
Fialkow PJ, Klein E, Klein G, Clifford P, Singh S. Fialkow PJ, et al. J Exp Med. 1973 Jul 1;138(1):89-102. doi: 10.1084/jem.138.1.89. J Exp Med. 1973. PMID: 4577623 Free PMC article. - Chromosome abnormalities in leukemia and lymphoma.
Rowley JD. Rowley JD. Ann Clin Lab Sci. 1983 Mar-Apr;13(2):87-94. Ann Clin Lab Sci. 1983. PMID: 6602585 - Clonal origin of chronic myelocytic leukemia.
Barr RD, Fialkow PJ. Barr RD, et al. N Engl J Med. 1973 Aug 9;289(6):307-9. doi: 10.1056/NEJM197308092890608. N Engl J Med. 1973. PMID: 4515677 No abstract available. - Biological implications of consistent chromosome rearrangements in leukemia and lymphoma.
Rowley JD. Rowley JD. Cancer Res. 1984 Aug;44(8):3159-68. Cancer Res. 1984. PMID: 6378364 Review. No abstract available. - Use of genetic markers to study cellular origin and development of tumors in human females.
Fialkow PJ. Fialkow PJ. Adv Cancer Res. 1972;15:191-226. doi: 10.1016/s0065-230x(08)60375-9. Adv Cancer Res. 1972. PMID: 4621753 Review. No abstract available.
Cited by
- MicroRNA Regulation of Human Breast Cancer Stem Cells.
Shimono Y, Mukohyama J, Nakamura S, Minami H. Shimono Y, et al. J Clin Med. 2015 Dec 25;5(1):2. doi: 10.3390/jcm5010002. J Clin Med. 2015. PMID: 26712794 Free PMC article. Review. - Genetics of neoplasia--impact of ecogenetics on oncogenesis. A review.
Purtilo DT, Paquin L, Gindhart T. Purtilo DT, et al. Am J Pathol. 1978 Jun;91(3):609-88. Am J Pathol. 1978. PMID: 207190 Free PMC article. Review. No abstract available. - Prospective identification of tumorigenic breast cancer cells.
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Al-Hajj M, et al. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8. doi: 10.1073/pnas.0530291100. Epub 2003 Mar 10. Proc Natl Acad Sci U S A. 2003. PMID: 12629218 Free PMC article. - Cancer stem cells of hepatocellular carcinoma.
Wang K, Sun D. Wang K, et al. Oncotarget. 2018 May 1;9(33):23306-23314. doi: 10.18632/oncotarget.24623. eCollection 2018 May 1. Oncotarget. 2018. PMID: 29796190 Free PMC article. Review. - Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.
Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, Diehn M, Liu H, Panula SP, Chiao E, Dirbas FM, Somlo G, Pera RA, Lao K, Clarke MF. Shimono Y, et al. Cell. 2009 Aug 7;138(3):592-603. doi: 10.1016/j.cell.2009.07.011. Cell. 2009. PMID: 19665978 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous